Council for Affordable Health Coverage brings many healthcare groups together
Over the years, there have been many cross-organizational efforts at addressing medication adherence—the $290-billion problem for healthcare (says CVS Caremark), and the $188-billion lost revenue opportunity for pharma (says Capgemini). A new one, Prescriptions for a Healthy America (www.adhereforhealth.org), organized by the Council for Affordable Health Coverage (CAHC), might stick: nearly 30 public-interest groups, lobbying organizations, payers, manufacturers and service providers have joined. Significantly, that list includes pharma companies (and PhRMA), the US Chamber of Commerce, physician societies and consumer groups—organizations that rarely come together. CAHC itself represents insurers and employer-payers, among others.
CAHC commissioned a study from a surveying company, Greenberg, Quinlan Rossner (Washington DC), finding that nearly two-thirds of Americans, across most economic and racial divides, do not take their meds as prescribed, and that a quarter of the population have stopped a medication without consulting their doctor. (Coincidentally, Kantar Health, with its annual National Health and Wellness Survey, released data this week that two-thirds of cancer patients [melanoma, leukemia and certain lung cancers] are non-adherent in one fashion or another.)
These data, by themselves, do not represent a changed attitude; adherence has been a recognized problem for decades. There appears to be a changing attitude about what to do about it: “The level of support occurring now is a new thing,” says Liz Whalley Buono, an executive at MeadWestvaco (Richmond, VA), which is a member of the new consortium. “There’s a realization that non-adherence adds to the cost of healthcare; it’s more, now, than just to say, ‘Do the right thing.’” MeadWestvaco’s place at the adherence table comes from its efforts to encourage the use of compliance packaging; the company was a winner in this year’s Healthcare Compliance Packaging Council new-product award. (And HCPC is also a member of the consortium.)
Whalley Buono (and others) point to a specific capability of CAHC: working on Capitol Hill to effect new legislation. The group has a list of five general goals (care coordination; patient education; quality measurement; healthcare IT; and research)—and is expected to lobby for increased funding of some or all of these from the federal government. The Affordable Care Act, and the funding for digitizing healthcare recordkeeping, already provide incentives; more are being looked for.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.